METROPOLIS.NSライブシグナル | Getagraph.comで利益を最大化

Live Chart Being Loaded With Signals

Commentary (8 5月 2024 @ 19:00):

Stats
本日の出来高	70 187.00
平均出来高	351 884
時価総額	90.38B
EPS	INR0 ( 2024-02-04 )
次の収益日	( INR13.40 ) 2024-05-13
Last Dividend	INR8.00 ( 2023-02-23 )
Next Dividend	INR0 ( N/A )
P/E	72.61
ATR14	INR1.253 (0.07%)

ボリューム相関

長: 0.11 (neutral)

短: 0.45 (neutral)

Signal:(55.386) Neutral

Metropolis Healthcare 相関

10 最も正の相関

10 最も負の相関

知っていましたか？

相関は、2つの変数間の関係を説明する統計的指標です。相関係数は-1から1までの値を取り、-1は完全な負の相関（1つの変数が増加すると、もう一方は減少する）、1は完全な正の相関（1つの変数が増加すると、もう一方も増加する）、0は相関がないことを示します（変数間に関係がない）。

相関は、株式だけでなく、どの2つの変数間の関係にも適用できます。これは、金融、経済学、心理学などの分野で一般的に使用されています。

Metropolis Healthcare 相関 - 通貨/商品

0.45
( neutral )

0.58
( weak )

-0.16
( neutral )

0.18
( neutral )

-0.87
( strong negative )

-0.72
( moderate negative )

Metropolis Healthcare 財務諸表

Annual	2022
収益:	INR11.48B
総利益:	INR8.88B (77.37 %)
EPS:	INR27.91

FY	2022
収益:	INR11.48B
総利益:	INR8.88B (77.37 %)
EPS:	INR27.91

FY	2022
収益:	INR12.28B
総利益:	INR9.41B (76.59 %)
EPS:	INR41.87

FY	2021
収益:	INR9.98B
総利益:	INR7.38B (73.92 %)
EPS:	INR35.97

Financial Reports:

No articles found.

Metropolis Healthcare Dividends

(Q3/22)	(Q4/22)	(Q1/23)	(Q2/23)	(Q3/23)	(Q4/23)	(Q1/24)	(Q2/24)	(Q3/24)	(Q4/24)
INR0 (N/A)	INR0 (N/A)	INR8.00 (N/A)	INR0 (N/A)	INR0 (N/A)	INR0 (N/A)	INR0 (N/A)	INR0 (N/A)	INR0 (N/A)	INR0 (N/A)

Metropolis Healthcare Dividend Information - Dividend Junior

Dividend Sustainability Score: 3.98 - low (32.22%) | Divividend Growth Potential Score: 3.78 - Decrease likely (24.30%)

Very Unsafe

High risk of being cut

Unsafe

Heightened risk of being cut

Borderline

Moderate risk of being cut

Safe

Unlikely to be cut

Very Safe

Very unlikely to be cut

Information

First Dividend	INR8.00	2020-02-13
Last Dividend	INR8.00	2023-02-23
Next Dividend	INR0	N/A
Payout Date	0000-00-00
Next Payout Date	N/A
# dividends	4	--
Total Paid Out	INR32.00	--
Avg. Dividend % Per Year	0.30%	--
Score	1.82	--
Div. Sustainability Score	3.98
Div.Growth Potential Score	3.78
Div. Directional Score	3.88	--

Next Divdend (Est)
(2024-12-31)

INR0 Estimate 0.00 %

Dividend Stability

0.06 Very Bad

Dividend Score

1.82

Pay Frequency

Annually

Yearly Payout

Year	Amount	Yield
2020	INR8.00	0.56%
2021	INR8.00	0.40%
2022	INR8.00	0.23%
2023	INR8.00	0.61%
2024	INR0	0.00%

Dividend Commentary

The company's low Dividend Sustainability Score (DSS) highlights potential challenges in upholding its current dividend levels. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. In conclusion, a more vigilant stance is recommended given the company's tentative dividend landscape.

Top 10 dividend Companies for NSE

Symbol	Title	Last dividend	Frequency	Years Dividend	Yearly Dividend
TECHNOE.NS	Dividend Junior	2023-09-15	Annually	16	1.13%
ONGC.NS	Dividend Knight	2023-08-18	Semi-Annually	28	4.00%
IOC.NS	Dividend Knight	2023-07-28	Semi-Annually	28	5.08%
CRAFTSMAN.NS	Dividend Junior	2023-06-19	Annually	3	0.13%
SHANTIGEAR.NS	Dividend Junior	2023-07-11	Annually	23	1.02%
MANGCHEFER.NS	Dividend Junior	2023-09-18	Annually	17	1.18%
GRANULES.NS	Dividend Junior	2023-08-03	Semi-Annually	20	0.29%
BAJAJCON.NS	Dividend Junior	2023-08-02	Annually	14	2.26%
TTKPRESTIG.NS	Dividend Junior	2023-07-21	Annually	20	0.43%
PLASTIBLEN.NS	Dividend Knight	2023-06-23	Annually	18	1.26%

Dividend Sustainability Score (DSS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
netProfitMarginTTM	0.108	1.500	7.85	10.00	[0 - 0.5]
returnOnAssetsTTM	0	1.200	0	0	[0 - 0.3]
returnOnEquityTTM	0.122	1.500	9.75	10.00	[0.1 - 1]
payoutRatioTTM	0	-1.000	0	0	[0 - 1]
currentRatioTTM	0	0.800	-5.00	-4.00	[1 - 3]
quickRatioTTM	0	0.800	-4.71	-3.76	[0.8 - 2.5]
cashRatioTTM	0	1.500	-1.111	-1.667	[0.2 - 2]
debtRatioTTM	0	-1.500	0	0	[0 - 0.6]
interestCoverageTTM	8.18	1.000	8.08	8.08	[3 - 30]
operatingCashFlowPerShareTTM	35.72	2.00	10.00	10.00	[0 - 30]
freeCashFlowPerShareTTM	35.72	2.00	10.00	10.00	[0 - 20]
debtEquityRatioTTM	0	-1.500	0	0	[0 - 2.5]
grossProfitMarginTTM	0.791	1.000	0.155	0.155	[0.2 - 0.8]
operatingProfitMarginTTM	0.163	1.000	8.74	8.74	[0.1 - 0.6]
cashFlowToDebtRatioTTM	0	1.000	-1.111	-1.111	[0.2 - 2]
assetTurnoverTTM	0	0.800	-3.33	-2.67	[0.5 - 2]
Total Score				3.98

Dividend Growth Score (DGS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
peRatioTTM	73.21	1.000	2.71	0	[1 - 100]
returnOnEquityTTM	0.122	2.50	9.84	10.00	[0.1 - 1.5]
freeCashFlowPerShareTTM	35.72	2.00	10.00	10.00	[0 - 30]
dividendYielPercentageTTM	0.224	1.500	4.39	0	[0 - 0.4]
operatingCashFlowPerShareTTM	35.72	2.00	10.00	10.00	[0 - 30]
payoutRatioTTM	0	1.500	0	0	[0 - 1]
pegRatioTTM	-2.20	1.500	-10.00	0	[0.5 - 2]
operatingCashFlowSalesRatioTTM	0.158	1.000	8.55	0	[0.1 - 0.5]
Total Score				3.78

Metropolis Healthcare

Metropolis Healthcare Limited provides diagnostic services in India. It offers clinical laboratory testing, and profiles and support services. The company provides diagnostic services for oncology, neurology, gynecology, and nephrology, as well as various health check-up packages for men, women, senior citizens, and youth and corporates. Its tests and profiles are used for prediction, early detection, diagnostic screening, confirmation, and/or monitoring of the disease. The company also offers corporate wellness and hospital laboratory solutions, as well as clinical research services. As of March 31, 2022, it operated 171 clinical laboratories, 9,000 pick-up points, and 704 assisted referral centers. The company was founded in 1980 and is headquartered in Mumbai, India.

リアルタイムの更新： Metropolis Healthcare [METROPOLIS.NS]

Upcoming Earnings Alert

Metropolis Healthcare Dividend Information - Dividend Junior

Dividend Commentary

Top 10 dividend Companies for NSE

Dividend Sustainability Score (DSS)

Dividend Growth Score (DGS)